Literature DB >> 15889450

Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.

Michelle J Khan1, Edward E Partridge, Sophia S Wang, Mark Schiffman.   

Abstract

BACKGROUND: Low socioeconomic status (SES) is a reported risk factor for cervical carcinoma, but few studies have taken into account adequately the possibly confounding effects of oncogenic human papillomavirus (HPV) infection as well as access to screening and subsequent treatment.
METHODS: Women (n = 5060 women) with a mean age of 27.5 years and with equivocal or mild cytologic cervical abnormalities were enrolled in the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion (ASCUS-LSIL) Triage Study (ALTS), a clinical trial that evaluated management strategies. The women were seen every 6 months for 2 years. The enrollment questionnaire assessed three indicators of SES: race/ethnicity, education, and source of payment for medical care. Multivariate logistic regression models were used to identify predictors of oncogenic HPV DNA positivity at enrollment and to assess associations between the SES indicators and risk of cervical intraepithelial neoplasia grade 3 (precancer) and carcinoma (> or = CIN3) identified throughout the study (n = 506 women) among oncogenic HPV-positive women (n = 3133 women).
RESULTS: SES indicators were not associated significantly with oncogenic HPV infection after adjustment for age at enrollment, recent and lifetime number of sexual partners, study center, and smoking history. Among women with oncogenic HPV, the risk of > or = CIN3 increased with decreasing education (less than high school education: odds ratio [OR], 2.4; 95% confidence interval [95%CI], 1.5-3.7 vs. completed college). Black women (OR, 0.5; 95%CI, 0.4-0.7) and white/Hispanic women (OR, 0.4; 95%CI, 0.2-0.8) were at decreased risk for > or = CIN3 compared with white/non-Hispanic women. The source of payment for medical care was not associated with risk.
CONCLUSIONS: Factors associated with lower SES, such as low education, may serve as a surrogate for unknown factors that influence progression to > or = CIN3 among women with oncogenic HPV infection. In this controlled setting with equalized follow-up and treatment, the decreased risk of > or = CIN3 associated with black and white/Hispanic race/ethnicity could be further examined. Ongoing efforts should emphasize methods for equalizing screening and follow-up among women of varying SES, regardless of race or ethnicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889450     DOI: 10.1002/cncr.21129

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009.

Authors:  Linda M Niccolai; Pamela J Julian; Alyssa Bilinski; Niti R Mehta; James I Meek; Daniel Zelterman; James L Hadler; Lynn Sosa
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.

Authors:  J R Montealegre; E C Peckham-Gregory; D Marquez-Do; L Dillon; M Guillaud; K Adler-Storthz; M Follen; M E Scheurer
Journal:  Gynecol Oncol       Date:  2017-12-21       Impact factor: 5.482

3.  Factors associated with pap testing among Hmong women.

Authors:  Dao Moua Fang; Serge Lee; Susan Stewart; May Ying Ly; Moon S Chen
Journal:  J Health Care Poor Underserved       Date:  2010-08

4.  Factors affecting risk of mortality in women with vaginal cancer.

Authors:  Chirag A Shah; Barbara A Goff; Kimberly Lowe; William A Peters; Christopher I Li
Journal:  Obstet Gynecol       Date:  2009-05       Impact factor: 7.661

5.  Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.

Authors:  Kathleen Settle; Marshall R Posner; Lisa M Schumaker; Ming Tan; Mohan Suntharalingam; Olga Goloubeva; Scott E Strome; Robert I Haddad; Shital S Patel; Earl V Cambell; Nicholas Sarlis; Jochen Lorch; Kevin J Cullen
Journal:  Cancer Prev Res (Phila)       Date:  2009-07-29

6.  Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.

Authors:  Mi Ah Han; Kui Son Choi; Hoo-Yeon Lee; Jae Kwan Jun; Kyu Won Jung; Sokbom Kang; Eun-Cheol Park
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

7.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

8.  Predictors of recurrence in patients with high-grade cervical intraepithelial neoplasia after cervical conization.

Authors:  Yan Ge; Yongli Liu; Yun Cheng; Yanbo Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

9.  Are there socioeconomic disparities in women having discussions on human papillomavirus vaccine with health care providers?

Authors:  Ker Yi Wong; Young Kyung Do
Journal:  BMC Womens Health       Date:  2012-10-04       Impact factor: 2.809

10.  Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2.

Authors:  Philip E Castle; Mark Schiffman; Cosette M Wheeler; Diane Solomon
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.